School personnel information

写真b

Chun Chijin


Organization 【 display / non-display

  • 2012.04.01 - 2016.04.30, Division of Medicine, Graduate School of Medicine, Doctoral Program Student

  • 2016.05.01 - 2017.09.30, Division of Medicine, Graduate School of Medicine, Specially Appointed Researcher

  • 2019.10.01 - , Division of Medicine, Graduate School of Medicine, Specially Appointed Researcher

 

Academic Papers 【 display / non-display

  • Parkinson's disease and iron, Mochizuki H, Choong CJ, Baba K, J Neural Transm (Vienna), 2020.02, Papers

  • Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology, Hayakawa H, Nakatani R, Ikenaka K, Aguirre C, Choong CJ, Tsuda H, Nagano S, Koike M, Ikeuchi T, Hasegawa M, Papa SM, Nagai Y, Mochizuki H, Baba K, Movement Disorders,35(2) 256-267, 2019.10, Papers

  • Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease., Uehara T, Choong CJ, Nakamori M, Hayakawa H, Nishiyama K, Kasahara Y, Baba K, Nagata T, Yokota T, Tsuda H, Obika S, Mochizuki H, Scientific reports,9(1) 7567, 2019.05, Other

  • Single injection of sustained-release prostacyclin analog ONO-1301-MS ameliorates hypoxic toxicity in the murine model of amyotrophic lateral sclerosis, Tada S, Okuno T, Shimizu M, Sakai Y, Sumi-Akamaru H, Kinoshita M, Yamashita K, Sanda E, Choong CJ, Namba A, Sasaki T, Koda T, Takata K, Miyagawa S, Sawa Y, Nakatsuji Y, Mochizuki H, Sci Rep,9(1) 5252-5252, 2019.03, Papers

  • A refined concept: α-synuclein dysregulation disease, Mochizuki H, Choong CJ, Masliah E, Neurochemistry International, 2018.01, Papers

display all >>